AIDS und Non-Hodgkin Lymphome - kardiale 
Erstmanifestation eines hochmalignen B-Zellymphoms nach 
18 Jahren HIV-Infektion

Sturm, Andreas; Noppeney, Richard; Reimer, J; Boss, B.; Baumgart, Daniel C.; Sundermann, Till; Sadony, V.; Gerken, G

doi:10.1055/s-2001-12430

Cited by 6 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Primary cardiac lymphomas, usually B-cell lymphomas usually involve the right atrium, and can present with conduction disturbances, secondary to infiltration of the conduction system [20], arrythmias, superior vena cava obstruction or heart failure. Chemotherapy and radiation therapy have shown mixed results in these patients [21-23]. …”

Section: Cardiac Disease In Patients With Hiv/aidsmentioning

confidence: 99%

Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem

Gopal¹,

Bhaskaran²,

Khalife³

et al. 2009

CCR

View full text Add to dashboard Cite

HIV/AIDS (Human immunodeficiency virus/ Acquired immuno deficiency syndrome) is a growing global problem, in terms of its incidence and mortality. Patients with HIV/AIDS are living much longer with HAART (Highly active antiretroviral therapy) therapy so much so that HIV/AIDS has now become a part of the chronic disease burden, like hypertension and diabetes. Patients with HIV/AIDS and symptoms suggestive of cardiac disease represent a diagnostic and therapeutic challenge in clinical practice; Cardiologists are more frequently encountering this problem. An algorithmic, anatomic approach to diagnosis, localizing disease to the endocardium, myocardium and pericardium can be useful. An intimate knowledge of opportunistic infections affecting the heart, effects of HAART therapy and therapy for opportunistic infections on the heart is needed to be able to formulate a differential diagnosis. Effects of HAART therapy, especially protease inhibitors on lipid and glucose metabolism, and their influence on progression to premature vascular disease require consideration. Treatment of cardiac disease, in HIV/AIDS patients can vary from non-HIV patients, based on drug interactions, differences in responsiveness, and other factors; and this area requires further research.

show abstract

Section: Cardiac Disease In Patients With Hiv/aidsmentioning

confidence: 99%

Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem

Gopal¹,

Bhaskaran²,

Khalife³

et al. 2009

CCR

View full text Add to dashboard Cite

show abstract

Evidence-Based Practice: Toward Optimizing Clinical Outcomes

2010

View full text Add to dashboard Cite

The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

show abstract